A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The main aim of this study is to assess how effective TAK-861 is for treating narcolepsy type 1 and if this effect is maintained over time. Participants will take TAK-861 for a few months and if they meet certain criteria, they will be randomly assigned (by chance, like flipping a coin) to continue taking TAK-861 or take placebo (fake medicine) for up to 4 weeks to see if their narcolepsy symptoms return.
Epistemonikos ID: b93a111fbf02a1c27dc1852d845e7426ccdd0ec5
First added on: Jan 24, 2026